Lehavim, Israel

Rom E Eliaz

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Rom E Eliaz from Lehavim, IL

Introduction: Rom E Eliaz is a notable inventor based in Lehavim, Israel, who has made significant contributions to the field of biomedical research. With a keen focus on innovative therapies, Eliaz holds a patent that addresses critical health challenges, particularly in the realm of dementia treatment.

Latest Patents: Rom E Eliaz is the inventor of a groundbreaking patent titled "Methods and Compositions with Immune Therapy for Treatment of Dementia." This patent encompasses novel antibodies, methods, and compositions designed for treating diseases that can be improved by blocking amyloid precursor protein (APP) cleavage. This innovative approach reflects Eliaz's commitment to advancing medical science and improving patient outcomes.

Career Highlights: Eliaz is currently affiliated with Ramot at Tel Aviv University Ltd., where he continues to develop and refine his innovative ideas. His work in this esteemed institution allows him access to cutting-edge research and collaboration opportunities with some of the brightest minds in the field.

Collaborations: Throughout his career, Rom E Eliaz has collaborated with esteemed colleagues, including Sarit Samira and Nurit Rachamim. These partnerships highlight the importance of teamwork in research and innovation, as they collectively strive to push the boundaries of medical science.

Conclusion: Rom E Eliaz is a pioneering inventor whose work stands to make a significant impact in the treatment of dementia through innovative immune therapy methods. As he continues his research at Ramot at Tel Aviv University Ltd., the future looks promising for both him and the advancements he is making in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…